Avecia operates as a Contract Manufacturing Organization (CMO) to support our client's programs, specializing in oligonucleotide production, and complex small molecule synthesis. As a member of the Nitto Denko Corporation (www.nitto.com), Avecia is committed to the future of the oligonucleotide market. We offer our customers oligo manufacturing capacity in two separate facilities (Milford, MA and Cincinnati, OH). Our Cincinnati facility also provides expanded pre-clinical oligo services (OliGrow), as well as small molecule expertise and production. Our mission is to continue to build value for our customers, as they progress through drug development into commercialization.